-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Channel Therapeutics Corp quarterly/annual Operating Income (Loss) history and growth rate from Q1 2023 to Q4 2024.
- Channel Therapeutics Corp Operating Income (Loss) for the quarter ending December 31, 2024 was -$1.83M, a 52.9% increase year-over-year.
- Channel Therapeutics Corp Operating Income (Loss) for the twelve months ending December 31, 2024 was -$7.57M, a 10.3% decline year-over-year.
- Channel Therapeutics Corp annual Operating Income (Loss) for 2024 was -$7.57M, a 10.3% decline from 2023.
- Channel Therapeutics Corp annual Operating Income (Loss) for 2023 was -$6.86M, a 196% decline from 2022.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)